Key facts
- Ilant Health’s last known valuation is $25.0M (Oct 2023).
- It has raised $42.9M; the latest was Early Stage VC ($37.4M) in Apr 2026.
- Notable investors include City Light Capital, Innovation Works, Life Extension Ventures, Cornucopian Capital, AlphaLab Health — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Ilant Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Ilant Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ilant Health
Operator of the obesity management and cardiometabolic health platform intended to remove stress and stigma from obesity and cardiometabolic treatment. The company's platform offers analytics, driven by unstructured machine learning, which provides insights around the potential to drive reductions in total cost of care and return on investment from obesity treatment, and helps to lose weight, enabling clients to improve outcomes while reducing costs and availing health plans.
- Sector
- Healthcare
- HQ
- Albany, NY, United States
- Founded
- 2022
- Employees
- 23
- Website
- ilanthealth.com/
- Ownership
- Privately Held (backing)
Ilant Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ilant Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ilant Health in its N-PORT filings yet. We sweep new filings monthly.